Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Sponsored Content | Blog | Greg Freiherr, Industry Consultant | Contrast Media | October 15, 2019

BLOG: How Customer Needs Impact Product Innovation

A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures

A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures. Graphic courtesy of Lior Molvin

When it comes to listing needs, patient safety ranks at the top. Just ask an imaging administrator.

“There is no way we can provide good quality customer care any other way,” said Brent Purscelley, director of ambulatory services at the Frederick Regional Health System.

But even when it comes to patient safety, distinguishing between needs and wants can get tricky. This is especially so when the frequency of patient complications gets very low.

Take CT contrast extravasations, for example. The leakage of contrast media from an intended blood vessel occurs very infrequently, only between 0.1 and 1.2 percent of administrations, according to the 2018 edition of the American College of Radiology (ACR) Manual on Contrast Media (version 10.3). Severe injuries due to extravasation may occur even more rarely.

“We have the technology today to monitor patients via sensors,” Purscelley said, “but it (extravasation) doesn’t happen often enough to really justify spending the additional money to do (the monitoring).”

The Role Of Smart Injectors

That’s where “smart” injectors come in. Not only do they alert technologists to ongoing problems, but –like black boxes on commercial airliners – they can record the data surrounding events, helping administrators understand the circumstances that led to them. Applied with preventative measures, these smart injectors can make a huge difference in patient safety.

To reduce the risk of extravasation, technologists at Frederick Regional Health System use a large gauge IV needle and tube; make sure needle placement is optimal; and assess patients for risk factors prior to contrast-enhanced scans, according to Christopher Nield, imaging supervisor there. The techs also use saline to test IV lines for stability prior to the injection of contrast agents. Additionally, the health system uses power injectors that alert techs to events that could indicate an ongoing extravasation.

The amount of time expended to do a procedure is also a factor. Increased turnaround time can decrease patient satisfaction, as it can increase provider and technologist frustration, according to Nield.

Bracco-made injectors record and display data about their performance. The appearance of a pressure spike on an injector display may indicate the occurrence of an extravasation. A networked smart injector can alert techs, radiologists and administrators to an ongoing event. The injector data can be interpreted in the context of the patient’s physical signs and the type of contrast-enhanced examination.

SmartInject solutions, built into Bracco-made injectors, display and document CT and MRI contrast administrations. These injectors can inject saline bolus chasers to push the contrast agent. If such a chaser is not used, a substantial amount of the contrast agent may linger near the injection site, potentially causing artifacts that block the visualization of important structures. Saline injections, before administration of the contrast medium, may also be used to test the stability of the IV needle and its placement in the vein.

Tracking Radiation Dose

Keeping track of radiation dose is critically important to minimizing the amount of patient radiation, which is essential to patient safety. Bracco’s NEXO information system for dose can track patient radiation exposure automatically regardless of the type of imaging system used. The multimodality radiation informatics system monitors and analyzes exposure data in real time and across the enterprise. When those data veer outside set parameters, NEXO sends an alert to physicians, technologists or administrators – whoever the system has been assigned to notify.

Similar capabilities regarding contrast media is achieved with the NEXO Contrast Management System, which uses SmartInject technology. As with the dose-oriented software, NEXO updates patient records by synchronizing with the RIS/PACS, EMR, or voice dictation system used in radiology.

The two systems – one for managing contrast, the other for keeping track of radiation – help meet not only patient needs but needs of the provider. Among provider needs is compliance with requirements, for example, ones set by The Joint Commission.

Because neither MRI nor ultrasound exposes patients to ionizing radiation, their use negates the need to track ionizing radiation, which accompanies CT and radiography/fluoroscopy. Issues surrounding contrast media, however, remain. Providers, therefore, must consider all sorts of risks. Among them is the lack of reliability.

Besides being easy to use, power injectors have to be rugged enough to stand up to the beatings that can be dished out in emergency rooms. Overall reliability, according to Nield, is critically important. “If we have an injector down, the scanner is out for some studies,” he said. “Then we have real issues.”

Editor’s Note: This is the third blog in a series titled Using Contrast Media. The first blog, Why Power Injectors Are Needed for High-quality Imaging, can be found here. The second blog, How Advances in Technology Help Patients and Providers, can be found here. The final blog in this four-part series will consider the value derived from smart injectors and informatics.

 

Related content:

BLOG: Why Power Injectors Are Needed for High-Quality Imaging

BLOG: How Advances in Technology Help Patients and Providers

Manual on Contrast Media

Related Content

This novel agent, based on the essential nutrient manganese, has strong potential as a safer alternative to currently used contrast agents
News | Contrast Media | December 28, 2020
December 28, 2020 — Adding a contrast-enhancing agent to...
Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.
News | Radiation Dose Management | December 11, 2020
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose manag
Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging solutions in an immersive digital experience at the first all-virtual Radiological Society of North America (RSNA) annual meeting being held November 29 through December 5.
News | Contrast Media Injectors | November 17, 2020
November 17, 2020 — Bracco Diagnostics Inc.
Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the 2020 annual meeting of the Radiological Society of North America (RSNA).
News | Contrast Media | November 17, 2020
November 17, 2020 — Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the
“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”  —Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”
—Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

Sponsored Content | Case Study | Radiation Dose Management | November 12, 2020
Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions.
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

Feature | Magnetic Resonance Imaging (MRI) | October 29, 2020
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a ver
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
The first and only FDA-approved gadolinium-based contrast agent for multi-patient dosing with an FDA-cleared Transfer Spike in the MR suite
News | Contrast Media | August 14, 2020
August 14, 2020 — The U.S.